Assessing the impact of the early COVID-19 era on antibiotic resistant threats in inpatient settings: A mixed-Poisson regression approach
Description
During the COVID-19 pandemic, increased antibiotic prescribing and infection prevention challenges coincided with antibiotic resistant (AR) infection increases. Clostridioides difficile (C. difficile) and methicillin-resistant Staphylococcus aureus
